0001214659-12-001758.txt : 20120420
0001214659-12-001758.hdr.sgml : 20120420
20120420092416
ACCESSION NUMBER: 0001214659-12-001758
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120331
FILED AS OF DATE: 20120420
DATE AS OF CHANGE: 20120420
EFFECTIVENESS DATE: 20120420
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: TANG CAPITAL MANAGEMENT LLC
CENTRAL INDEX KEY: 0001232621
IRS NUMBER: 680517275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-14822
FILM NUMBER: 12769676
BUSINESS ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE
STREET 2: SUITE 510
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-200-3830
MAIL ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE
STREET 2: SUITE 510
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
13F-HR
1
a4191213fhr.txt
REPORT FOR THE QUARTER ENDED MARCH 31, 2012
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 13F
FORM 13F COVER PAGE
Report for the Calendar Year or Quarter Ended: March 31, 2012
Check here if Amendment [ ]; Amendment Number: __
This Amendment (Check only one): [ ] is a restatement.
[ ] adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: Tang Capital Management, LLC
Address: 4747 Executive Drive, Suite 510, San Diego, CA 92121
Form 13F File Number: 28-14822
The institutional investment manager filing this report and the person by whom
it is signed hereby represent that the person signing the report is authorized
to submit it, that all information contained herein is true, correct and
complete, and that it is understood that all required items, statements,
schedules, lists, and tables, are considered integral parts of this form.
Person Signing this Report on Behalf of Reporting Manager:
Name: Kevin C. Tang
Title: Managing Director of Tang Capital Management, LLC
Phone: 858-200-3830
Signature, Place, and Date of Signing:
/s/ Kevin C. Tang San Diego, CA April 20, 2012
----------------------- ------------------------ -------------------------
[Signature] [City, State] [Date]
Report Type (Check only one.):
[X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager
are reported in this report.)
[_] 13F NOTICE. (Check here if no holdings reported are in this report, and all
holdings are reported by other reporting manager(s).)
[_] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this
reporting manager are reported in this report and a portion are reported by
other reporting manager(s).)
List of Other Managers Reporting for this Manager: NONE
FORM 13F SUMMARY PAGE
REPORT SUMMARY:
NUMBER OF OTHER INCLUDED MANAGERS: 1
FORM 13F INFORMATION TABLE ENTRY TOTAL: 29
FORM 13F INFORMATION TABLE VALUE TOTAL: 428,891
(thousands)
LIST OF OTHER INCLUDED MANAGERS:
Provide a numbered list of the name(s) and Form 13F file number(s) of all
institutional investment managers with respect to which this report is filed,
other than the manager filing this report.
1 Kevin C. Tang 28-14818
FORM 13F INFORMATION TABLE
VALUE SHARES/ SH/ PUT/ INVSTMT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DSCRETN MANAGERS SOLE SHARED NONE
ACHILLION PHARMACEUTICALS INC COM 00448Q201 4,314 450,344 SH SOLE 450,344 0 0
ALEXZA PHARMACEUTICALS INC COM 015384100 5,993 9,676,264 SH SOLE 9,676,264 0 0
AMLYIN PHARMACUETICALS INC COM 032346108 44,064 1,765,400 SH SOLE 1,765,400 0 0
ARDEA BIOSCIENCES INC COM 03969P107 81,243 3,733,582 SH SOLE 3,733,582 0 0
ARDEA BIOSCIENCES INC COM 03969P107 4,269 196,177 SH SHARED-
DEFINED 1 82,141 114,036 0
AVANIR PHARMACEUTICALS INC COM 05348P401 1,754 512,858 SH SOLE 512,858 0 0
BIOMARIN PHARMACEUTICALS INC NOTE 2.500% 3/29/13 09061GAC5 6,393 3,000,000 PRN SOLE 3,000,000 0 0
BIOSANTE PHARMACEUTICALS INC COM 09065V203 1,924 2,828,711 SH SOLE 2,828,711 0 0
CADENCE PHARMACEUTICALS INC COM 12738T100 1,110 300,000 SH SOLE 300,000 0 0
CYCLACEL PHARMACEUTICALS INC PFD CONV EX 6% 23254L207 703 277,993 SH SOLE 277,993 0 0
DENDREON CORP COM 24823Q107 848 79,600 SH SHARED-
DEFINED 1 0 79,600 0
DENDREON CORP NOTE 4.750% 6/15/14 24823QAB3 5,165 4,000,000 PRN SOLE 4,000,000 0 0
DENDREON CORP NOTE 2.875% 1/15/16 24823QAC1 15,723 19,515,000 PRN SOLE 19,515,000 0 0
DEPOMED INC COM 249908104 19,549 3,122,920 SH SOLE 3,122,920 0 0
ENDOCYTE INC COM 29269A102 2,319 465,763 SH SOLE 465,763 0 0
HUMAN GENOME SCIENCES INC COM 444903108 1,312 159,250 SH SOLE 159,250 0 0
INTERMUNE INC NOTE 2.500% 9/15/18 45884XAE3 15,150 17,000,000 PRN SOLE 17,000,000 0 0
MANNKIND CORP COM 56400P201 6,545 2,649,619 SH SOLE 2,649,619 0 0
MANNKIND CORP NOTE 3.750% 12/15/13 56400PAA0 22,238 39,979,000 PRN SOLE 39,979,000 0 0
NAVIDEA BIOPHARMACEUTICALS INC COM 63937X103 810 246,984 SH SOLE 246,984 0 0
NEKTAR THERAPEUTICS INC COM 640268108 1,584 200,000 SH SOLE 200,000 0 0
NEKTAR THERAPEUTICS INC NOTE 3.250% 9/28/12 640268AH1 79,309 78,907,000 PRN SOLE 78,907,000 0 0
ONCOGENEX PHARMACEUTICALS INC COM 68230A106 11,072 833,100 SH SOLE 833,100 0 0
PDL BIOPHARMA INC NOTE 2.875% 2/15/15 69329YAA2 41,625 37,474,000 PRN SOLE 37,474,000 0 0
SALIX PHARMACEUTICALS INC COM 795435106 15,750 300,000 SH SOLE 300,000 0 0
SAVIENT PHARMACEUTICALS COM 80517Q100 408 187,200 SH SOLE 187,200 0 0
SAVIENT PHARMACEUTICALS INC NOTE 4.750% 2/1/18 80517QAA8 9,753 23,500,000 PRN SOLE 23,500,000 0 0
SPECTRUM PHARMACEUTICALS INC COM 84763A108 22,455 1,777,895 SH SOLE 1,777,895 0 0
VANDA PHARMACEUTICALS INC COM 921659108 5,509 1,150,050 SH SOLE 1,150,050 0 0